The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.
Q3 2025 Management View Louis Torchio, President, CEO & Director, opened by highlighting the closure of the Penns Woods ...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...
This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, USA.The ...
The US Food and Drug Administration (FDA) on Friday finalized three guidance documents related to de novo classification requests for medical devices. Devices using the de novo classification process ...
The president of the planned Georgia Skyline Bank says he's cautiously optimistic that his group can raise $35 million of ...
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma To our knowledge, this is the largest study to date to comprehensively evaluate NK-t-AML and provides a framework that ...
ASC giant United Surgical Partners International had a huge year in 2024, solidifying its position as the biggest ASC company in the country. A key driver of this growth is the company’s de novo ...
De novo genes are evolution’s magic trick—new genes appearing from non-coding DNA, much like a rabbit pulled from a hat. Once considered impossible, de novo genes have been identified in Drosophila ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback